New prognostic indexes for overall survival in malignant mesothelioma treated with pemetrexed or best supportive care in the real world

New prognostic indexes for overall survival in malignant mesothelioma treated with pemetrexed or best supportive care in the real world - New prognostic indexes for overall survival in malignant mesothelioma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011733

Enrollment

200

Registered

2013-09-12

Start date

2013-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant pleural mesothelioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients pathologically confirmed with maliganant pleural mesothelioma in Hyogo Prefectural Amagasaki Hospital or Hyogo College of Medicine Hospital between 4/1/2007 to 3/31/2013

Exclusion criteria

Exclusion criteria: Double cancer patients. Treated by chemotherapy, radiotherapy before diagnosis. Treated with trimodality therapy, extra-pleural pneumonectomy, pleurectomy, decortication, or palliative chemotherapy without pemetrexed.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Countries

Japan

Contacts

Public ContactKATAOKA Yuki

Kyoto University School of Public Health at Graduate School of Medicine Department of Healthcare Epidemiology

kataoka.yuki.23c@st.kyoto-u.ac.jp075-753-4645

Outcome results